Perspectives on Enquiry & Evidence

Cytel's blog featuring the latest industry insights.

Featured post

Aligning Clinical Trial Design with Investment Priorities

When working with investors, it’s critical that drug and device developers consider how their clinical trial design aligns with investment priorities. Natalia Muehlemann and Ari Brettman (Blackstone Life Sciences) discuss what investors look for when evaluating clinical development programs, and the value of simulation-guided design in informing decisions and facilitating communication with investors.

Read full article

Perspectives on Enquiry and Evidence

September 20, 2023

FSP Behind the Scenes with Anwaya Joshi, Programming Senior Team Lead

Cytel’s Functional Service Provision (FSP) teams work on exciting projects with biotech and pharmaceutical companies as...

Read article

August 30, 2023

FSP Behind the Scenes with Jeff Thompson, R Senior Statistical Programmer

Cytel’s Functional Service Provision (FSP) teams work on exciting projects with biotech and pharmaceutical companies as...

Read article

August 26, 2020

Career Perspectives: Interview with Yannis Jemiai, Chief Scientific Officer

As Chief Scientific Officer, Dr. Yannis Jemiai plays a pivotal role in maintaining Cytel’s well-established reputation...

Read article

August 18, 2020

Career Perspectives: Interview with Mrudula Joshi, Associate Director, Statistical Programming Services

Mrudula Joshi joined Cytel in July 2005 as a young SAS programmer. Last month, she celebrated her 15th year work...

Read article

April 7, 2020

Career Perspectives: Interview with Marc Lefebvre-Gouy, Statistical Programmer

Cytel has industry-leading experts in Statistical Programming with years of SAS® Programming expertise and in-depth...

Read article